165 related articles for article (PubMed ID: 20726710)
1. Transient activation of the ALT pathway in human primary fibroblasts exposed to high-LET radiation.
Berardinelli F; Antoccia A; Cherubini R; De Nadal V; Gerardi S; Cirrone GA; Tanzarella C; Sgura A
Radiat Res; 2010 Nov; 174(5):539-49. PubMed ID: 20726710
[TBL] [Abstract][Full Text] [Related]
2. PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening.
Osterwald S; Deeg KI; Chung I; Parisotto D; Wörz S; Rohr K; Erfle H; Rippe K
J Cell Sci; 2015 May; 128(10):1887-900. PubMed ID: 25908860
[TBL] [Abstract][Full Text] [Related]
3. Telomere maintenance by telomerase and by recombination can coexist in human cells.
Cerone MA; Londono-Vallejo JA; Bacchetti S
Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
[TBL] [Abstract][Full Text] [Related]
4. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
5. Telomere length in mammalian cells exposed to low- and high-LET radiations.
Sgura A; Antoccia A; Berardinelli F; Cherubini R; Gerardi S; Zilio C; Tanzarella C
Radiat Prot Dosimetry; 2006; 122(1-4):176-9. PubMed ID: 17223635
[TBL] [Abstract][Full Text] [Related]
6. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
[TBL] [Abstract][Full Text] [Related]
7. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation.
Chung I; Leonhardt H; Rippe K
J Cell Sci; 2011 Nov; 124(Pt 21):3603-18. PubMed ID: 22045732
[TBL] [Abstract][Full Text] [Related]
8. PML is required for telomere stability in non-neoplastic human cells.
Marchesini M; Matocci R; Tasselli L; Cambiaghi V; Orleth A; Furia L; Marinelli C; Lombardi S; Sammarelli G; Aversa F; Minucci S; Faretta M; Pelicci PG; Grignani F
Oncogene; 2016 Apr; 35(14):1811-21. PubMed ID: 26119943
[TBL] [Abstract][Full Text] [Related]
9. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.
Draskovic I; Arnoult N; Steiner V; Bacchetti S; Lomonte P; Londoño-Vallejo A
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15726-31. PubMed ID: 19717459
[TBL] [Abstract][Full Text] [Related]
10. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
Yeager TR; Neumann AA; Englezou A; Huschtscha LI; Noble JR; Reddel RR
Cancer Res; 1999 Sep; 59(17):4175-9. PubMed ID: 10485449
[TBL] [Abstract][Full Text] [Related]
11. The alternative lengthening of telomeres pathway may operate in non-neoplastic human cells.
Slatter TL; Tan X; Yuen YC; Gunningham S; Ma SS; Daly E; Packer S; Devenish C; Royds JA; Hung NA
J Pathol; 2012 Feb; 226(3):509-18. PubMed ID: 22250043
[TBL] [Abstract][Full Text] [Related]
12. Cyogenetics effects in AG01522 human primary fibroblasts exposed to low doses of radiations with different quality.
Nieri D; Berardinelli F; Sgura A; Cherubini R; De Nadal V; Gerardi S; Tanzarella C; Antoccia A
Int J Radiat Biol; 2013 Sep; 89(9):698-707. PubMed ID: 23607438
[TBL] [Abstract][Full Text] [Related]
13. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
14. Telomeric Recombination Induced by DNA Damage Results in Telomere Extension and Length Heterogeneity.
Liu H; Xie Y; Zhang Z; Mao P; Liu J; Ma W; Zhao Y
Neoplasia; 2018 Sep; 20(9):905-916. PubMed ID: 30118998
[TBL] [Abstract][Full Text] [Related]
15. hRad21 overexpresses and localizes to the ALT-associated promyelocytic leukemia body in ALT cells.
Zhao B; Wang ZJ; Yi BQ; Ma HC; Xu HM
Cancer Biol Ther; 2010 Jun; 9(12):978-83. PubMed ID: 20364118
[TBL] [Abstract][Full Text] [Related]
16. PML and TRF2 protein expression in hereditary and sporadic colon cancer.
Plevová P; Bouchal J; Fiurásková M; Papezová M; Krepelová A; Curík R; Foretová L; Navrátilová M; Zapletalová J; Posolda T; Kolár Z
Neoplasma; 2007; 54(4):269-77. PubMed ID: 17822315
[TBL] [Abstract][Full Text] [Related]
17. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.
Londoño-Vallejo JA; Der-Sarkissian H; Cazes L; Bacchetti S; Reddel RR
Cancer Res; 2004 Apr; 64(7):2324-7. PubMed ID: 15059879
[TBL] [Abstract][Full Text] [Related]
18. Orphan nuclear receptors-induced ALT-associated PML bodies are targets for ALT inhibition.
Gaela VM; Hsia HY; Joseph NA; Tzeng WY; Ting PC; Shen YL; Tsai CT; Boudier T; Chen LY
Nucleic Acids Res; 2024 Jun; 52(11):6472-6489. PubMed ID: 38752489
[TBL] [Abstract][Full Text] [Related]
19. An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres.
Wang Y; Erdmann N; Giannone RJ; Wu J; Gomez M; Liu Y
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10256-60. PubMed ID: 16000404
[TBL] [Abstract][Full Text] [Related]
20. Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres.
Slatter T; Gifford-Garner J; Wiles A; Tan X; Chen YJ; MacFarlane M; Sullivan M; Royds J; Hung N
Am J Pathol; 2010 Dec; 177(6):2694-700. PubMed ID: 21037079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
